- Zacks•12 hours ago
Shares of Achillion Pharmaceuticals, Inc. (ACHN) lost almost 9% on Feb 24, 2017, in spite of the company reporting narrower-than-expected fourth-quarter loss a day before.
- Business Wire•13 hours ago
Celgene Corporation plans to present at two upcoming investor conferences where Celgene management will provide an overview of the Company. The conferences will be webcast live and will be available in the Investor Relations section of the Company’s website at www.celgene.com.
- Zacks•3 days ago
Emergent BioSolutions, Inc. (EBS) reported earnings of 74 cents per share in the fourth quarter of 2016, which surpassed the Zacks Consensus Estimate of 60 cents. However, the reported figure decreased from 77 cents earned in the year-ago period.
CELG : Summary for Celgene Corporation - Yahoo Finance
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||121.66 x 100|
|Ask||121.89 x 100|
|Day's Range||118.01 - 122.00|
|52 Week Range||94.39 - 127.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||48.91|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|